Olov Andersson's Group
Bridging developmental biology and drug discovery, we use the zebrafish model to elucidate organogenesis and related mechanisms of disease.
We are currently focusing on pancreatic beta-cell regeneration. Increasing the number of insulin-producing beta-cells might prove a better treatment for diabetes, which is at present controlled but not cured by insulin injections. Diabetes is characterized by elevated blood glucose levels, a consequence of insufficient insulin supply and/or insulin resistance. Despite mechanistic differences, both type 1 and late-stage type 2 diabetes feature depletion of beta-cells. Experimental ablation of beta-cells by chemical treatment or partial pancreatectomy in zebrafish and rodents is followed by significant recovery of the beta-cell mass, indicating that the pancreas has the capacity to regenerate. This regenerative capacity could potentially be exploited therapeutically - if the underlying mechanisms were better understood.
We perform unbiased chemical-genetic screens in zebrafish to identify compounds, signals and cellular mechanisms that promote beta-cell regeneration. The zebrafish model is particularly good for studying pancreatic development in vivo. First, the simplicity of its organ structures (e.g. the zebrafish embryo has only one pancreatic islet during the first week of development) allows rapid analysis of cellular changes. Second, zebrafish embryos are amenable to efficient transgenesis and drug delivery.
By using a wide range of techniques, we are investigating three different cellular mechanisms of beta-cell regeneration:
- Induction of beta-cell neogenesis
- Promotion of beta-cell proliferation
- Generation of ectopic insulin-producing cells
In sum, we aim to identify and characterize compounds, signalling pathways and cellular mechanisms that can induce or increase beta-cell regeneration, with the overarching goal of developing new therapies for diabetes.
|Olov Andersson||Associate Professor/Principal Investigator|
|Jeremie Charbord||Senior lab manager|
|Lian Chu||Postdoctoral researcher|
|Daniel Colquhoun||Postdoctoral researcher|
|Christos Karampelias||PhD student|
|Ka-Cheuk Liu||Senior lab manager|
|Jiarui Mi||PhD student|
|Lipeng Ren||PhD student|
|Ulla Wargh||Fish caretaker|
Insulin-producing β-cells regenerate ectopically from a mesodermal origin under the perturbation of hemato-endothelial specification.
Liu KC, Villasenor A, Bertuzzi M, Schmitner N, Radros N, Rautio L, Mattonet K, Matsuoka RL, Reischauer S, Stainier DY, Andersson O
Elife 2021 Aug;10():
Reinforcing one-carbon metabolism via folic acid/Folr1 promotes β-cell differentiation
Karampelias C, Rezanejad H, Rosko M, Duan L, Lu J, Pazzagli L, Bertolino P, Cesta CE, Liu X, Korbutt GS, Andersson O
Nature Communications volume 12, Article number: 3362 (2021)
In vivo screen identifies a SIK inhibitor that induces β cell proliferation through a transient UPR.
Charbord J, Ren L, Sharma RB, Johansson A, Ågren R, Chu L, Tworus D, Schulz N, Charbord P, Stewart AF, Wang P, Alonso LC, Andersson O
Nat Metab 2021 May;3(5):682-700
Inhibition of Cdk5 Promotes β-Cell Differentiation From Ductal Progenitors.
Liu KC, Leuckx G, Sakano D, Seymour PA, Mattsson CL, Rautio L, et al
Diabetes 2018 01;67(1):58-70
Critical role for adenosine receptor A2a in β-cell proliferation.
Schulz N, Liu KC, Charbord J, Mattsson CL, Tao L, Tworus D, et al
Mol Metab 2016 11;5(11):1138-1146
IGFBP1 increases β-cell regeneration by promoting α- to β-cell transdifferentiation.
Lu J, Liu KC, Schulz N, Karampelias C, Charbord J, Hilding A, et al
EMBO J. 2016 09;35(18):2026-44
Adenosine signaling promotes regeneration of pancreatic β cells in vivo.
Andersson O, Adams BA, Yoo D, Ellis GC, Gut P, Anderson RM, et al
Cell Metab. 2012 Jun;15(6):885-94